Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 08, 2023 16:05 ET | Source: Caribou Biosciences, Inc.

Caribou Biosciences to Participate in the Oppenheimer 33rd Annual Healthcare Conference

BERKELEY, Calif., March 08, 2023 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel...
March 07, 2022 16:11 ET | Source: Caribou Biosciences, Inc.

Caribou Biosciences to Present at Upcoming Investor Conferences

BERKELEY, Calif., March 07, 2022 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that Rachel...
March 04, 2021 08:00 ET | Source: F-star Therapeutics, Inc.

F-star Therapeutics to Present at Upcoming Investor Conferences

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 04, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next...
February 24, 2021 08:20 ET | Source: Hamilton Thorne Ltd.

Hamilton Thorne to Participate in Oppenheimer Annual Healthcare Conference on March 17, 2021

BEVERLY, Mass. and TORONTO, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted...
March 15, 2017 17:01 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Oppenheimer 27th Annual Healthcare Conference

ROCKVILLE, Md., March 15, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
December 04, 2015 08:00 ET | Source: Flexion Therapeutics, Inc.

Flexion Therapeutics to Present at Oppenheimer 26th Annual Healthcare Conference

BURLINGTON, Mass., Dec. 04, 2015 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that Michael Clayman, M.D., President and Chief Executive Officer, will present at the...